Spero Therapeutics Inc (SPRO)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.06B
EV to revenue ratio (TTM)
0.24
EV to ebitda
1.53
Financial Performance
Revenue (TTM)
$0.05B
Gross profit (TTM)
$0.03B
EBITDA
$0.01B
Profitability
Operating margin (TTM)
14.10%
Profit margin
15.70%
Return on assets (TTM)
7.19%
Return on equity (TTM)
19.20%
Per Share Metrics
Revenue per share (TTM)
$0.83
EPS
$0.14
Diluted EPS (TTM)
$0.14
Book value
$0.76
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
7.29
Trailing P/E
7.29
Forward P/E
n/a
PEG ratio
0
Price to sales ratio (TTM)
1.26
Price to book ratio (TTM)
1.33
Growth
Quarterly earnings growth (YoY)
-95.60%
Quarterly revenue growth (YoY)
75.30%
Analyst Sentiment
Strong buy
0
Buy
1
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.56